|
66 Companies |
|
64 Products |
|
64 Products |
|
38 Mechanisms of Action |
|
0 Trials |
|
1523 News |
|
| «12...7891011121314151617...3031» |
- | paracetamol / Generic mfg., ibuprofen / Generic mfg.
New P4 trial: The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine (clinicaltrials.gov) - Aug 11, 2014
P4, N=160, Not yet recruiting, Sponsor: Duke University
- |||| FluLaval Quadrivalent (influenza vaccine) / GSK
Trial completion: Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age (clinicaltrials.gov) - Aug 11, 2014
P2, N=316, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed
- ||| Clinical: Influenza Vaccination in Cancer Patients (clinicaltrials.gov) - Aug 11, 2014
P=N/A, N=130, Not yet recruiting, Sponsor: Seoul National University Hospital
- | New P2 trial: H7N9 Mix and Match With MF59 in Healthy Elderly Persons (clinicaltrials.gov) - Aug 11, 2014
P2, N=600, Not yet recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- ||||| Fluzone Quadrivalent (influenza vaccine) / Sanofi
New P4 trial: A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years (clinicaltrials.gov) - Aug 8, 2014
P4, N=400, Not yet recruiting, Sponsor: bioCSL PTY LTD
- Trial completion: MUCOFLU: Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination (clinicaltrials.gov) - Aug 8, 2014
P4, N=439, Completed, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial primary completion date: Influenza A H1N1: Retrospective Analysis of PCR Confirmed Cases of H1N1 Infections in Styria - Risk Factors, Clinical Features and Outcome. (clinicaltrials.gov) - Aug 7, 2014
P=N/A, N=800, Recruiting, Sponsor: Medical University of Graz
Active, not recruiting --> Completed Trial primary completion date: Jun 2014 --> Dec 2014
- Trial primary completion date: Effects of Yoga on Objective and Self-reported Health Indicators Among Female and Male Individuals (clinicaltrials.gov) - Aug 7, 2014
P=N/A, N=90, Recruiting, Sponsor: Karolinska Institutet
Trial primary completion date: Jun 2014 --> Dec 2014 Trial primary completion date: Jun 2015 --> Jun 2016
- ||||||| Trial completion, Preclinical: A Study to Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications (clinicaltrials.gov) - Aug 7, 2014
P3, N=430, Completed, Sponsor: Novartis Vaccines
Trial primary completion date: Jun 2015 --> Jun 2016 Active, not recruiting --> Completed
- oseltamivir / Generic mfg.
Enrollment change: Safety and Efficacy of Oseltamivir in Children Younger Than One Year of Age (clinicaltrials.gov) - Aug 6, 2014
P2, N=0, Withdrawn, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed N=250 --> 0
- Trial termination: Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip (clinicaltrials.gov) - Aug 6, 2014
P=N/A, N=60, Terminated, Sponsor: Duke University
N=250 --> 0 Active, not recruiting --> Terminated; The Sponsor terminated the study.
- Trial completion, Enrollment change: Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot) (clinicaltrials.gov) - Aug 6, 2014
P1, N=31, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Terminated; The Sponsor terminated the study. Active, not recruiting --> Completed | N=40 --> 31
- |||||||||| Fluarix Quadrivalent (influenza vaccine) / GSK
New P3 trial: A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children (clinicaltrials.gov) - Aug 4, 2014
P3, N=1860, Not yet recruiting, Sponsor: GlaxoSmithKline
- || Trial initiation date, Trial primary completion date: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of Age (clinicaltrials.gov) - Aug 4, 2014
P1, N=420, Not yet recruiting, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed | N=40 --> 31 Initiation date: Oct 2014 --> Dec 2015 | Trial primary completion date: Dec 2014 --> Feb 2016
- ||||||| Trial completion, Head-to-Head: Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older (clinicaltrials.gov) - Aug 1, 2014
P3, N=2680, Completed, Sponsor: Novartis Vaccines
Initiation date: Oct 2014 --> Dec 2015 | Trial primary completion date: Dec 2014 --> Feb 2016 Active, not recruiting --> Completed
- Enrollment open: Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections (clinicaltrials.gov) - Jul 30, 2014
P4, N=100, Recruiting, Sponsor: Chinese University of Hong Kong
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- || Fluarix Quadrivalent (influenza vaccine) / GSK
Enrollment closed: Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults (clinicaltrials.gov) - Jul 30, 2014
P1, N=240, Active, not recruiting, Sponsor: Crucell Holland BV
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- ||||| Fluad Quadrivalent (inactivated quadrivalent influenza vaccine) / CSL Behring
Enrollment closed: Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children. (clinicaltrials.gov) - Jul 30, 2014
P3, N=10616, Active, not recruiting, Sponsor: Novartis Vaccines
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- ||||| Trial initiation date, Trial primary completion date: Evaluation of the Efficacy and Safety of Two Ibuprofen Combination Products for the Treatment of the Common Cold and Flu in Latin America (clinicaltrials.gov) - Jul 23, 2014
P3, N=750, Not yet recruiting, Sponsor: Pfizer
Recruiting --> Active, not recruiting Initiation date: Apr 2014 --> Apr 2015 | Trial primary completion date: Sep 2014 --> Sep 2015
- Clinical: Effect of Influenza Vaccination of Healthcare Workers (HCW) on the Risk of Influenza in Patients Hospitalized in Short Stays Units (clinicaltrials.gov) - Jul 23, 2014
P=N/A, N=400, Recruiting, Sponsor: Hospices Civils de Lyon
- |||| Trial completion: Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects (clinicaltrials.gov) - Jul 23, 2014
P2, N=1392, Completed, Sponsor: Novartis Vaccines
Initiation date: Apr 2014 --> Apr 2015 | Trial primary completion date: Sep 2014 --> Sep 2015 Active, not recruiting --> Completed
- Trial completion: Characterization of Influenza-like Illness in Mexico (clinicaltrials.gov) - Jul 17, 2014
P=N/A, N=5818, Completed, Sponsor: Mexican Infectious Disease Network
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Quinvaxem (diphtheria, Tetanus, whole-cell pertussis- HiB - HepB) / GSK
Trial completion: A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject (clinicaltrials.gov) - Jul 15, 2014
P3, N=400, Completed, Sponsor: Crucell Holland BV
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Studies of Avian Influenza Transmission to Humans in Egypt (clinicaltrials.gov) - Jul 14, 2014
P=N/A, N=1000, Completed, Sponsor: St. Jude Children's Research Hospital
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Trial primary completion date: Flu Vaccine Against Childhood Pneumonia, Bangladesh (clinicaltrials.gov) - Jul 12, 2014
P3, N=3408, Recruiting, Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
Active, not recruiting --> Completed Trial primary completion date: Dec 2013 --> Dec 2014
- Trial primary completion date: Surveillance of Influenza Virus Among Children With Febrile Respiratory Complaints Attending the Pediatric Clinic of the First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, Mainland China (clinicaltrials.gov) - Jul 12, 2014
P=N/A, N=16000, Recruiting, Sponsor: St. Jude Children's Research Hospital
Trial primary completion date: Dec 2013 --> Dec 2014 Trial primary completion date: Sep 2014 --> Dec 2014
- FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Biomarker, Trial primary completion date: Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines (clinicaltrials.gov) - Jul 10, 2014
P1, N=38, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Trial primary completion date: Sep 2014 --> Dec 2014 Trial primary completion date: Jun 2014 --> Dec 2014
- |||| oseltamivir / Generic mfg., nitazoxanide / Generic mfg.
Trial primary completion date: Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza (clinicaltrials.gov) - Jul 8, 2014
P3, N=1800, Recruiting, Sponsor: Romark Laboratories L.C.
Trial primary completion date: Jun 2014 --> Dec 2014 Trial primary completion date: May 2014 --> Dec 2014
- || Dectova (zanamivir) / GSK
Trial primary completion date: Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital (clinicaltrials.gov) - Jul 8, 2014
P2, N=200, Recruiting, Sponsor: GlaxoSmithKline
Trial primary completion date: May 2014 --> Dec 2014 Trial primary completion date: Sep 2011 --> May 2015
- |||| Dectova (zanamivir) / GSK
Enrollment open, Trial primary completion date: Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital (clinicaltrials.gov) - Jul 8, 2014
P2, N=200, Recruiting, Sponsor: GlaxoSmithKline
Trial primary completion date: Sep 2011 --> May 2015 Active, not recruiting --> Recruiting | Trial primary completion date: Sep 2011 --> May 2015
- ||||| MenHibrix (GSK 792014) / GSK
Enrollment closed: Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix (clinicaltrials.gov) - Jul 8, 2014
P3, N=600, Active, not recruiting, Sponsor: GlaxoSmithKline
Active, not recruiting --> Recruiting | Trial primary completion date: Sep 2011 --> May 2015 Recruiting --> Active, not recruiting
- ||||| oseltamivir / Generic mfg., nitazoxanide / Generic mfg.
Enrollment change, Trial primary completion date: Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza (clinicaltrials.gov) - Jul 2, 2014
P3, N=1400, Recruiting, Sponsor: Romark Laboratories L.C.
Recruiting --> Active, not recruiting N=750 --> 1400 | Trial primary completion date: May 2014 --> Dec 2014
- Trial primary completion date: Effects of BCG on Influenza Induced Immune Response (clinicaltrials.gov) - Jul 2, 2014
P2/3, N=40, Recruiting, Sponsor: Radboud University
N=750 --> 1400 | Trial primary completion date: May 2014 --> Dec 2014 Trial primary completion date: Oct 2014 --> Jul 2014
- Enrollment change: Effects of BCG on Influenza Induced Immune Response (clinicaltrials.gov) - Jul 2, 2014
P2/3, N=40, Recruiting, Sponsor: Radboud University
Trial primary completion date: Oct 2014 --> Jul 2014 N=72 --> 40
- Enrollment open, Enrollment change, Trial primary completion date: Effects of BCG on Influenza Induced Immune Response (clinicaltrials.gov) - Jul 2, 2014
P2/3, N=40, Recruiting, Sponsor: Radboud University
N=72 --> 40 Not yet recruiting --> Recruiting | N=72 --> 40 | Trial primary completion date: Oct 2014 --> Jul 2014
- oseltamivir / Generic mfg.
Trial termination: PECOS: Panama and El Salvador Children's Oseltamivir Study (clinicaltrials.gov) - Jul 1, 2014
P4, N=721, Terminated, Sponsor: Centers for Disease Control and Prevention
Not yet recruiting --> Recruiting | N=72 --> 40 | Trial primary completion date: Oct 2014 --> Jul 2014 Recruiting --> Terminated; Slower than anticipated participant accrual
- ||||| Fluarix Quadrivalent (influenza vaccine) / GSK
Trial initiation date: An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children (clinicaltrials.gov) - Jul 1, 2014
P3, N=12000, Active, not recruiting, Sponsor: GlaxoSmithKline
Recruiting --> Terminated; Slower than anticipated participant accrual Initiation date: Oct 2011 --> May 2014
- oseltamivir / Generic mfg.
Enrollment change, Trial termination: PECOS: Panama and El Salvador Children's Oseltamivir Study (clinicaltrials.gov) - Jul 1, 2014
P4, N=721, Terminated, Sponsor: Centers for Disease Control and Prevention
Initiation date: Oct 2011 --> May 2014 N=1400 --> 721 | Recruiting --> Terminated; Slower than anticipated participant accrual
- ||| New P1 trial: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of Age (clinicaltrials.gov) - Jul 1, 2014
P1, N=420, Not yet recruiting, Sponsor: GlaxoSmithKline
- Enrollment change: Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014 (clinicaltrials.gov) - Jun 27, 2014
P=N/A, N=656, Completed, Sponsor: Columbia University
N=1400 --> 721 | Recruiting --> Terminated; Slower than anticipated participant accrual N=3300 --> 656
- Enrollment change: FluAlert: Influenza Vaccine Alerts for Providers in the Electronic Health Record (clinicaltrials.gov) - Jun 27, 2014
P=N/A, N=6145, Completed, Sponsor: Columbia University
N=3300 --> 656 N=14988 --> 6145
- Trial completion, Enrollment change: Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014 (clinicaltrials.gov) - Jun 27, 2014
P=N/A, N=656, Completed, Sponsor: Columbia University
N=14988 --> 6145 Recruiting --> Completed | N=3300 --> 656
- Trial completion, Enrollment change: FluAlert: Influenza Vaccine Alerts for Providers in the Electronic Health Record (clinicaltrials.gov) - Jun 27, 2014
P=N/A, N=6145, Completed, Sponsor: Columbia University
Recruiting --> Completed | N=3300 --> 656 Active, not recruiting --> Completed | N=14988 --> 6145
- Enrollment closed: A Phase I Study of Candidate Influenza Vaccines MVA-NP+M1 and ChAdOx1 NP+M1 (clinicaltrials.gov) - Jun 27, 2014
P1, N=48, Active, not recruiting, Sponsor: University of Oxford
Active, not recruiting --> Completed | N=14988 --> 6145 Recruiting --> Active, not recruiting
- |||| Rebif (human IFN-β-1a) / EMD Serono
Enrollment open: RELIEF: A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis (clinicaltrials.gov) - Jun 26, 2014
P4, N=218, Recruiting, Sponsor: Merck KGaA
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Trial completion: Adult Influenza Vaccination Text Message Reminders (clinicaltrials.gov) - Jun 26, 2014
P=N/A, N=7250, Completed, Sponsor: Columbia University
Not yet recruiting --> Recruiting Not yet recruiting --> Completed
- ||||||| Fluvirin (inactivated influenza virus vaccine) / CSL Behring
Trial completion, Preclinical: Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age (clinicaltrials.gov) - Jun 26, 2014
P3, N=2055, Completed, Sponsor: Novartis Vaccines
Not yet recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Pilot Text Message for Influenza Vaccination (clinicaltrials.gov) - Jun 26, 2014
P=N/A, N=1000, Completed, Sponsor: Columbia University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| IVACFLU-A/H5N1 (whole virion monovalent A/H5N1 influenza vaccine) - Institute of Vaccines and Biological Medical / IVAC
New P1 trial: Influenza A/H5N1 Vaccine Clinical Trial (IVACFLU-A/H5N1) - Phase 1 (clinicaltrials.gov) - Jun 26, 2014
P1, N=76, Recruiting, Sponsor: Institute of Vaccines and Medical Biologicals (IVAC)
- ||| IVACFLU-A/H5N1 (whole virion monovalent A/H5N1 influenza vaccine) - Institute of Vaccines and Biological Medical / IVAC
Enrollment open: Influenza A/H5N1 Vaccine Clinical Trial (IVACFLU-A/H5N1) - Phase 1 (clinicaltrials.gov) - Jun 26, 2014
P1, N=76, Recruiting, Sponsor: Institute of Vaccines and Medical Biologicals (IVAC)
Active, not recruiting --> Completed Not yet recruiting --> Recruiting